Cellular, Tissue and Gene Therapies Advisory Committee
February 5, 2008 Meeting
Date and Time:
The meeting will be held by teleconference on February 5, 2008 from 12 noon to approximately 3:15 p.m. Eastern Time.
Location:
National Institutes of Health, Building 29B, Conference Room C, 9000 Rockville Pike, Bethesda, MD.
Contact Persons:
Gail Dapolito or Danielle Cubbage, Food and Drug Administration, 1401 Rockville Pike, HFM-71, Rockville, MD 20853, 301-827-0314, or FDA Advisory Committee Information Line, 1-800-741-8138 (301-443-0572 in the Washington, DC area), code 3014512389. Please call the Information Line for up-to-date information on this meeting.
Agenda:
On February 5, 2008, the Committee will meet in open session to hear updates of research programs in 1) the Division of Therapeutic Proteins and the Division of Monoclonal Antibodies, Office of Biotechnology Products, Center for Drug Evaluation and Research, FDA. The Committee will also meet in a Closed Session to discuss intramural research programs.
Oral Presentations:
Oral presentations from the public will be scheduled between approximately 1:30 p.m. and 2:30 p.m. Time allotted for each presentation may be limited. Those desiring to make formal oral presentations should notify the contact person before January 21, 2008. A speakerphone will be provided at the specified location for public participation on-site, during the Open Session.